Patient adherence to prescribed therapy is widely recognized as a significant issue. Several factors, such as poor taste, administration difficulty, dosing frequency, and inconvenience, are attributed to the lack of patient acceptance and adherence to a prescribed regimen. Additionally, patient non-adherence can result in billions of lost revenue annually for the pharmaceutical industry due to prescriptions not filled or not re-filled by patients.
In this complimentary webinar, you will gain valuable insights in to how patient-centric drug formulations can help you overcome oral drug delivery challenges.
This webinar includes 4 case studies featuring unique solutions for patients with diverse needs:
- Providing the most convenient dosage formulation for better patient adherence
- Taste masking drugs with an unpleasant or bitter taste
- Orally disintegrating tablet technology for pediatric and elderly patients, and those who have difficulty swallowing
- Demonstrating bioequivalence and achieving regulatory approval with new formulations
- Improving the safety profile of drugs and reducing health care costs
You will also have an opportunity to take part in an exclusive Q&A session with Nadine Maalouf, PharmD, and Stefania Pagani, PhD., from Aptalis Pharmaceutical Technologies. Let our experts answer your questions and see how Aptalis Pharmaceutical Technologies can help transform your oral delivery challenges into proprietary product solutions.
Register now and transform the value of your portfolio.
Nadine Maalouf, PharmD,
Director, Licensing
Nadine Maalouf, PharmD, is Director, Licensing, at Aptalis Pharmaceutical Technologies where she is responsible for handling ex-US new business development and the out-licensing of commercialized products. Ms. Maalouf has extensive experience in formulation solutions as well as out-licensing of global (ex-USA) commercialized products with ongoing territory approvals and expansions.
Stefania Pagani, PhD.,
Associate Formulation Scientist, R&D
Stefania Pagani is an Associate Formulation Scientist at Aptalis Pharmaceutical Technologies where she is involved in developing new drug products, modified release dosage forms, taste masking technologies and bioavailability enhancement. Dr Pagani has several years of experience in pharmaceutical technologies and problem solving in scale up activities.
- Providing convenient dosage formulations and taste masking drugs for better patient adherence
- ODTs for pediatric and elderly patients, and those who have difficulty swallowing
- Demonstrating bioequivalence and achieving regulatory approval with new formulations
- Improving the safety profile of drugs and reducing health care costs
- R&D
- CEO
- VP
- GM
- Business Development
- Product Management
- Scientists/Chemists
- Formulation
